BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38913501)

  • 1. Cogan-Like Syndrome Following Nivolumab Immunotherapy for Metastatic Cutaneous Melanoma.
    Philip AM; Fernandez-Santos CC; Dolinko AH; Massoudi Y; Valerio T; Maleki A; Foster CS
    Ocul Immunol Inflamm; 2024 Jun; ():1-5. PubMed ID: 38913501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cogan syndrome.
    Orsoni JG; Zavota L; Pellistri I; Piazza F; Cimino L
    Cornea; 2002 May; 21(4):356-9. PubMed ID: 11973382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.
    Obata S; Saishin Y; Teramura K; Ohji M
    Case Rep Ophthalmol; 2019; 10(1):67-74. PubMed ID: 31097947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review.
    Yilmaz Tugan B; Ozkan B; Sonmez O
    Semin Ophthalmol; 2021 Nov; 36(8):794-799. PubMed ID: 33780309
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cogan I syndrome: too often detected too late? A contribution to early diagnosis of Cogan I syndrome].
    Pleyer U; Baykal HE; Rohrbach JM; Bohndorf M; Rieck P; Reimann J; Kuhnt P; Saal J
    Klin Monbl Augenheilkd; 1995 Jul; 207(1):3-10. PubMed ID: 7564135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Ocular Rosacea following Combined Ipilimumab and Nivolumab Treatment for Metastatic Malignant Skin Melanoma.
    Brouwer NJ; Haanen JBAG; Jager MJ
    Ocul Oncol Pathol; 2017 Sep; 3(3):188-192. PubMed ID: 29071268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral Sensorineural Hearing Loss Associated With Nivolumab Therapy for Stage IV Malignant Melanoma.
    Tampio AJF; Dhanireddy S; Sivapiragasam A; Nicholas BD
    Ear Nose Throat J; 2021 Jun; 100(3_suppl):286S-291S. PubMed ID: 32703012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral uveitis and macular edema induced by Nivolumab: a case report.
    Theillac C; Straub M; Breton AL; Thomas L; Dalle S
    BMC Ophthalmol; 2017 Dec; 17(1):227. PubMed ID: 29195497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Vogt-Koyanagi-Harada disease and impressive response to immune checkpoint blockade in metastatic melanoma.
    Gambichler T; Seifert C; Lehmann M; Lukas C; Scheel C; Susok L
    Immunotherapy; 2020 May; 12(7):439-444. PubMed ID: 32308086
    [No Abstract]   [Full Text] [Related]  

  • 10. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
    Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
    Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cogan-I-syndrome.A rare differential diagnosis in progressive sensorineural hearing loss].
    Massinger C; Keilmann A
    HNO; 2003 Jan; 51(1):66-70. PubMed ID: 28271196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cogan's syndrome is more than just keratitis: a case-based literature review.
    Wang Y; Tang S; Shao C; Liu Y
    BMC Ophthalmol; 2023 May; 23(1):212. PubMed ID: 37173630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Cogan's syndrome: a case report.
    Ying YL; Hirsch BE
    Am J Otolaryngol; 2010; 31(4):279-82. PubMed ID: 20015756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cogan's syndrome: a cause of progressive hearing deafness.
    Cundiff J; Kansal S; Kumar A; Goldstein DA; Tessler HH
    Am J Otolaryngol; 2006; 27(1):68-70. PubMed ID: 16360829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cogan's syndrome associated with orbital inflammation.
    Shahid FL; Mukherjee R; Knapp C
    Orbit; 2013 Jun; 32(3):206-7. PubMed ID: 23617562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vertigo and ocular inflammation: Cogan syndrome].
    van Oosterhout WRPJ; Stroomer JWG; Rösken GRHJ
    Ned Tijdschr Geneeskd; 2022 Jul; 166():. PubMed ID: 35899725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
    Afzal MZ; Mabaera R; Shirai K
    J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric Cogan´s syndrome - review of literature, case report and practical approach to diagnosis and management.
    Rücklová K; von Kalle T; Koitschev A; Gekeler K; Scheltdorf M; Heinkele A; Blankenburg F; Kötter I; Hospach A
    Pediatr Rheumatol Online J; 2023 Jun; 21(1):54. PubMed ID: 37291629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A shifty diagnosis: Cogan's syndrome. A case report and review of the literature.
    Migliori G; Battisti E; Pari M; Vitelli N; Cingolani C
    Acta Otorhinolaryngol Ital; 2009 Apr; 29(2):108-13. PubMed ID: 20111622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY.
    Madoe A; Schauwvlieghe PP; Jacob J
    Retin Cases Brief Rep; 2023 Sep; 17(5):611-615. PubMed ID: 37643052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.